Vienna (ots/PRNewswire) - New integrated radiology solutions designed to deliver economic value, increase clinical performance Royal Philips will demonstrate advanced image quality, visualization and clinical decision support at the European Congress of Radiology [https://www.myesr.org/cms/website.php?id=/en/ecr_2014.htm ], March 6-10, in Vienna, Austria. Building on more than 20 years of digital imaging experience, the ...
Mumbai, India (ots/PRNewswire) - Saffola has recently launched Saffola Total, oil with multi-seed technology* which has twice the antioxidant power than olive oil^ and higher antioxidant power than most oils. Antioxidants are known to prevent the generation of free radicals. Saffola Total has a specially designed ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies, announced today it has completed its previously announced debt financing issuing a total of 7,744 units at a price of CDN $1,000 per unit for total ...
Lyon, France (ots/PRNewswire) - - Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi Pasteur, the vaccines division of Sanofi , announced today its further commitment to the international community's efforts to complete polio ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Global Initiatives Underscore Shire's Long-term Commitment to the Rare Disease Community Shire plc today announced its support of Rare Disease Day and invites others to join them in its continued commitment to the rare disease community. Observed annually on the last day of February, Rare Disease Day is coordinated at the international level by the European Organisation for Rare ...
Amsterdam (ots/PRNewswire) - New event to accelerate and nurture South Korea's "Pharma 2020 Vision" UBM Live has today announced the latest addition to its global pharmaceutical events portfolio, CPhI Korea 2014, which will take place on September 2nd-3rd 2014 at the COEX in Seoul, South Korea. (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a ) South Korea is ...
Lyon, France (ots/PRNewswire) - European Committee for Medicinal Products for Human Use evaluated positively a 2-dose schedule for Gardasil(R) in adolescents Sanofi Pasteur MSD announced today that its quadrivalent HPV vaccine, Gardasil(R) has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the ...
Lausanne, Switzerland (ots/PRNewswire) - - Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist - Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in ...
2014 International Summit of Cooperatives
Quebec (ots/PRNewswire) - The cooperative movement plays a key role in the global economy, representing over a million businesses with a billion members employing 100 million workers. Despite their great resilience in the wake of the 2008 financial crisis, cooperatives are no strangers to financing, capitalization, ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, announced today that the US Food & Drug Administration (FDA) has approved the production of VPRIV(R) drug substance (velaglucerase alfa for injection) in Shire's manufacturing facility at 400 Shire Way, Lexington, ...
Gosselies, Belgium (ots/PRNewswire) - iTeos Therapeutics SA today announced the filing of the Company's first patent applications protecting proprietary inhibitors of the intracellular enzyme TDO2, which is expressed at high levels in specific cancers. iTeos Therapeutics has collaborated with Ludwig Cancer Research over the last year to identify small molecule ...
London (ots/PRNewswire) - UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers and pharmacies, has integrated its sales, marketing and medical service offerings within one division to better meet the needs of pharmaceutical clients. In addition to ...
Coalition of Physicians for Social Justice
Montreal (ots/PRNewswire) - As Belgium prepares to become the first country in the world to enact a law permitting euthanasia of children, Jessica Saba, 4, of Lachine, Quebec Canada asks the King of Belgium to refuse to sign the legislation. (Photo: http://photos.prnewswire.com/prnh/20140202/667550 ) "For the sake ...
Coalition of Physicians for Social Justice
Montreal (ots/PRNewswire) - As Belgium prepares to become the first country in the world to enact a law permitting euthanasia for children, Jessica Saba, 4, of Lachine, Quebec, Canada asks the King of Belgium to refuse to sign the legislation. (Photo: http://photos.prnewswire.com/prnh/20140202/667550 ) "For the sake ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - First-ever, Europe-wide scientific initiative designed to accelerate virology clinical research & transform clinical outcomes for patients Three European virology researchers were awarded research grants this week based on their proposed research projects to investigate novel ways to cure ...
London (ots/PRNewswire) - The UK's flagship health and safety conference announces speaker programme. The theme of this year's event is Inspiring Leadership. This year's IOSH conference in London will welcome more than 60 expert speakers from across the globe including health & safety leaders, government figures and representatives from law and academia. The conference takes places June 17-18 at the London ExCel. (Logo: ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies, announced that it received a Notice of Allowance for U.S. Application Serial Number US2012/025014 from the United States Patent and Trademark Office ...
Medivation Inc and Astellas Pharma Inc
San Francisco And Tokyo (ots/PRNewswire) - --Study demonstrates statistically significant benefits in overall survival, radiographic progression-free survival, and a delay (17 months) in the time to initiation of chemotherapy-- Medivation Inc. and Astellas Pharma Inc. announced final results on the primary and ...
Takeda Pharmaceutical Company Limited and Dainippon Sumitomo Pharma Co., Ltd.
Osaka, Japan (ots/PRNewswire) - Dainippon Sumitomo Pharma Co., Ltd. ("DSP") (Head Office: Osaka, Japan) and Takeda Pharmaceutical Company Limited ("Takeda") (Head Office: Osaka, Japan) today jointly announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMA), has ...
Hatfield, England (ots/PRNewswire) - The investigational monoclonal antibody amatuximab (development code: MORAb-009), has today been granted orphan drug designation (ODD) for the treatment of malignant mesothelioma by the European Commission. Malignant mesothelioma is a rare form of cancer that affects an estimated ...
Amsterdam (ots/PRNewswire) - Country report to contain contrasting insights into the American pharma economy from European and domestic perspectives CPhI Worldwide [http://www.cphi.com ], organised by UBM Live, announces the launch of the CPhI Pharma Insights USA market report. A joint venture with InformEx [http://www.informex.com ], the report will provide European ...
E.S.PKU (European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria)
Alter, Belgium (ots) - First ever pan-European perspective on optimal care identifies key challenges in this rare genetic disease The first ever pan-European patient/carer perspective on optimal care of the rare genetic disorder phenylketonuria (PKU) has been published in the Orphanet Journal of Rare Diseases. This paper, supported by the European Society for ...
Hatfield, England (ots/PRNewswire) - Fycompa(R) (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), launches today in Spain. The new therapy is indicated for the adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 ...
Calgary, Alberta (ots/PRNewswire) - "RVX-208 treated patients have significant lower MACE events in high risk CVD patients" TSX Exchange Symbol: RVX Resverlogix Corp. today announced new information arising from its ongoing analysis of data from both the SUSTAIN and ASSURE trials in atherosclerotic patients with high risk for recurrent events. This analysis, performed ...
Amsterdam (ots/PRNewswire) - Kilbee responsible for driving the portfolio globally including increased emphasis on digital and content CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group Director of the UBM Pharma Portfolio. Central to the role is responsibility for the strategic development and delivery of market leading event brands CPhI, ICSE, Inno-Pack and P-MEC, held in Europe, ...
Berlin (ots/PRNewswire) - Scientists in Europe are stepping up their efforts to bring Golden Rice into production, with its promise to alleviate one of the world's scourges, vitamin A deficiency. They have organized a nine-city European tour led by Dr. Patrick Moore, co-founder and former leader of Greenpeace. ...
Oudenaarde, Belgium (ots/PRNewswire) - Discover the machine behind the famous technology and its applications at the Europlasma booth 35266, in LVCC South Hall 4, January 7th till 10th Belgium based Europlasma, a world leader in low pressure plasma technology, is happy to present at CES 2014 its nanocoating systems ...
Hatfield, England (ots/PRNewswire) - Halaven(R) (eribulin) has received reimbursement approval in the Czech Republic as a highly innovative drug for patients with metastatic breast cancer, effective from the 1 January 2014. Eribulin is the first, single-agent chemotherapy to demonstrate a prolonged overall survival ...
Darmstadt, Germany (ots/PRNewswire) - - The European Commission's approval is based on the CHMP positive opinion - Label update comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the ...
Takeda Pharmaceuticals International GmbH
Zurich Switzerland (ots) - Takeda Pharmaceuticals International GmbH ("Takeda") announced that the European decentralised procedure (DCP) was positively concluded for dexlansoprazole, a proton pump inhibitor (PPI) with a new dual- delayed release technology for the treatment of reflux disease. The regulatory process ...